000 | 01595 a2200457 4500 | ||
---|---|---|---|
005 | 20250518092523.0 | ||
264 | 0 | _c20210305 | |
008 | 202103s 0 0 eng d | ||
022 | _a1365-4632 | ||
024 | 7 |
_a10.1111/ijd.14853 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThakur, Vishal | |
245 | 0 | 0 |
_aPonatinib-induced lamellar ichthyosis-like eruption. _h[electronic resource] |
260 |
_bInternational journal of dermatology _cMay 2020 |
||
300 |
_ae156-e157 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAcitretin _xtherapeutic use |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aDrug Eruptions _xdiagnosis |
650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
650 | 0 | 4 |
_aEmollients _xtherapeutic use |
650 | 0 | 4 |
_aExanthema _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIchthyosis, Lamellar _xchemically induced |
650 | 0 | 4 |
_aImidazoles _xadverse effects |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
650 | 0 | 4 |
_aPyridazines _xadverse effects |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMalhotra, Pankaj | |
700 | 1 | _aLad, Deepesh | |
700 | 1 | _aChatterjee, Debajyoti | |
700 | 1 | _aVinay, Keshavamurthy | |
700 | 1 | _aDogra, Sunil | |
773 | 0 |
_tInternational journal of dermatology _gvol. 59 _gno. 5 _gp. e156-e157 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ijd.14853 _zAvailable from publisher's website |
999 |
_c30765201 _d30765201 |